[{"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA050441"], "brand_name": ["CLEOCIN PHOSPHATE"], "generic_name": ["CLINDAMYCIN PHOSPHATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-0728", "0009-0870", "0009-0775", "0009-0902", "0009-3124", "0009-3447", "0009-3381", "0009-3375", "0009-3382", "0009-6582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["CLINDAMYCIN PHOSPHATE"], "rxcui": ["205964", "309335", "309336", "309339", "685574", "685576", "685578", "706461", "1737244", "1737245", "1737578", "1737579", "1737581", "1737582"], "spl_id": ["cb513686-3220-4de2-8be6-f941273ae842"], "spl_set_id": ["05a75685-0af5-407c-ac57-e380c882b49d"], "package_ndc": ["0009-0870-21", "0009-0870-26", "0009-0775-20", "0009-0775-26", "0009-0902-11", "0009-0902-18", "0009-0728-05", "0009-0728-09", "0009-3124-01", "0009-3124-03", "0009-3447-01", "0009-3447-03", "0009-3381-01", "0009-3381-02", "0009-3375-01", "0009-3375-02", "0009-3382-01", "0009-3382-02", "0009-6582-02", "0009-6582-01"], "is_original_packager": [true], "unii": ["EH6D7113I8"]}, "product_type": "Drugs", "event_id": "82386", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Guam", "recall_number": "D-1068-2019", "product_description": "Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-3124-01", "product_quantity": "820 cartons (25 vials per carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point", "recall_initiation_date": "20190315", "center_classification_date": "20190329", "termination_date": "20220811", "report_date": "20190410", "code_info": "Lot#: T78191, Exp.04/2019, T97494, Exp.07/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0832-2019", "product_description": "Dr. King's SafeCare Rx Allergies: Food Chemicals U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955004226, NDC 57955-0042-2", "product_quantity": "694 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 062415X Exp. 06/18; 052815G Exp. 05/18; 051716T Exp. 05/19; 092216J Exp. 09/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83497", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1840-2019", "product_description": "Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.", "product_quantity": "648 vials", "reason_for_recall": "Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.", "recall_initiation_date": "20190806", "center_classification_date": "20190823", "termination_date": "20220728", "report_date": "20190904", "code_info": "Lot #: 101107A, Exp. 10/19."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202867"], "brand_name": ["MOXIFLOXACIN"], "generic_name": ["MOXIFLOXACIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-422"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE"], "rxcui": ["403818"], "spl_id": ["40262fef-9713-4538-b96b-c44b257d6a25"], "spl_set_id": ["ae77e219-8af9-4aa4-96d3-05c9726a1d3c"], "package_ndc": ["68180-422-01"], "is_original_packager": [true], "upc": ["0368180422013"], "unii": ["B8956S8609"]}, "product_type": "Drugs", "event_id": "82037", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed by 5 wholesalers, 6 drug chains, 4 mail order pharmacies and 1 mail order pharmacy/supermarket who may have further distribute the product throughout the United States.", "recall_number": "D-0484-2019", "product_description": "Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 Manufactured by: lupin Limited Pithampur (M.P.) 454 775 India. NDC 68180-422-01", "product_quantity": "43,860 3ml  bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.", "recall_initiation_date": "20190201", "center_classification_date": "20190208", "termination_date": "20200626", "report_date": "20190220", "code_info": "Lot Numbers: H705562, H705563, EXP. 11/2019; H800616, EXP. 01/2020"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209207"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-2130"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["39623a94-8b73-17c6-e063-6294a90a4c31"], "spl_set_id": ["f4dad3d6-1366-4bdf-99eb-370ab74a6b9e"], "package_ndc": ["51672-2130-8", "51672-2130-1"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0300-2020", "product_description": "Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz. (120 mL), Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-8", "product_quantity": "182,986 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: E875131667, E875231667, Exp 4/20; J871033189, J871133189, Exp 9/20; A972934375, A973034375, Exp 12/20", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075742"], "brand_name": ["RANITIDINE HYDROCHLORIDE"], "generic_name": ["RANITIDINE HYDROCHLORIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-129", "55111-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RANITIDINE HYDROCHLORIDE"], "rxcui": ["198190", "198192"], "spl_id": ["9741e6f4-a2dc-7543-1138-da97eafe11bd"], "spl_set_id": ["7bf94bf7-fa11-70be-9f65-fe26a3db5a63"], "package_ndc": ["55111-129-60", "55111-129-05", "55111-130-30", "55111-130-01"], "is_original_packager": [true], "unii": ["BK76465IHM"]}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0180-2020", "product_description": "Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0346-2020", "product_description": "Viatrexx-Neuro, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0460, NDC 73069-375-41.", "product_quantity": "13 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00020, Exp. May: 2020"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0801-2019", "product_description": "Dr. King's SafeCare Rx Expressed Sexual Issues, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955125020, NDC 57955-1257-2", "product_quantity": "10 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 051216M Exp. 05/19"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1756-2019", "product_description": "CARBOPLATIN 174 MG / 250ml NS IVPB; CARBOPLATIN 240 MG / 250 ML NS IVPB; CARBOPLATIN 750 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 895 MG / 250 ML NACL 0.9% IVPB; CARBOPLATIN 235 MG / 250ml NS IVPB  CARBOPLATIN 716 MG / 250 ML D5W IVPB; CARBOPLATIN 400 MG / 500 ML NS IVPB; CARBOPLATIN 500 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 575 MG / 500 ML NS IVPB; CARBOPLATIN 307 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 766 MG / 500 ML NS IVPB; CARBOPLATIN 684 / 250 ML NACL 0.9% IVPB; CARBOPLATIN 260 MG / 100 ML D5W IVPB  CARBOPLATIN 360 MG /100 ML NACL 0.9% IVPB; CARBOPLATIN 274 MG / 250 ML D5W IVPB; CARBOPLATIN 240 MG / 100 ML D5W IVPB; CARBOPLATIN 750 MG / 250 ML NS IVPB; CARBOPLATIN 260 MG / 250 ML NS IVPB; CARBOPLATIN 460 MG / 250 ML NS IVPB; CARBOPLATIN 175 MG / 250 ML NS IVPB; CARBOPLATIN 229.4 MG / 500 ML NS IVPB  CARBOPLATIN 780 MG / 100 ML NACL 0.9% IVPB; CARBOPLATIN 140 MG / 250 ML NS IVPB; CARBOPLATIN 408 MG / 500 ML NS IVPB  CARBOPLATIN 847 MG / 250 ML D5W IVPB; CARBOPLATIN 560 MG / 250 ML D5W IVPB; CARBOPLATIN 180 MG / 250 ML NS IVPB; CARBOPLATIN 200 MG / 250 ML D5W IVPB; CARBOPLATIN 238 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0888-2019", "product_description": "Dr. King's SafeCare Rx Sporting Edge, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 35795500312, NDC 57955-0031-2", "product_quantity": "142 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 122815C Exp. 12/18; 101716A Exp. 10/19"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0405-2020", "product_description": "CVS Health Fast Acting Lubricant Eye Drops Preservative Free, Item#: 994882, Product Size: 0.6 mL x 24 ct, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "58,704 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "RIN 09/19   RKP 11/19    SAR 01/20   SCG 03/20   SED 5/20   SLC 12/20   TBE 02/21   TBL 02/21"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA050441"], "brand_name": ["CLEOCIN PHOSPHATE"], "generic_name": ["CLINDAMYCIN PHOSPHATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-0728", "0009-0870", "0009-0775", "0009-0902", "0009-3124", "0009-3447", "0009-3381", "0009-3375", "0009-3382", "0009-6582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["CLINDAMYCIN PHOSPHATE"], "rxcui": ["205964", "309335", "309336", "309339", "685574", "685576", "685578", "706461", "1737244", "1737245", "1737578", "1737579", "1737581", "1737582"], "spl_id": ["cb513686-3220-4de2-8be6-f941273ae842"], "spl_set_id": ["05a75685-0af5-407c-ac57-e380c882b49d"], "package_ndc": ["0009-0870-21", "0009-0870-26", "0009-0775-20", "0009-0775-26", "0009-0902-11", "0009-0902-18", "0009-0728-05", "0009-0728-09", "0009-3124-01", "0009-3124-03", "0009-3447-01", "0009-3447-03", "0009-3381-01", "0009-3381-02", "0009-3375-01", "0009-3375-02", "0009-3382-01", "0009-3382-02", "0009-6582-02", "0009-6582-01"], "is_original_packager": [true], "unii": ["EH6D7113I8"]}, "product_type": "Drugs", "event_id": "82386", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Guam", "recall_number": "D-1067-2019", "product_description": "Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02", "product_quantity": "67 cartons (25 vials per carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point", "recall_initiation_date": "20190315", "center_classification_date": "20190329", "termination_date": "20220811", "report_date": "20190410", "code_info": "Lot #: T97469, Exp. 7/2019, W28574, Exp.09/2019"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82782", "recalling_firm": "Heritage Pharmaceuticals, Inc.", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1287-2019", "product_description": "Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only  Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108  SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India.   Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816. 1-866-901-DRUG (3784)  NDC 23155-645-10", "product_quantity": "3012 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer", "recall_initiation_date": "20190503", "center_classification_date": "20190521", "termination_date": "20201116", "report_date": "20190529", "code_info": "Lot CLO17007A    Lot CLO17008A       Lot CLO17009A ; Exp 11/2019"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2020", "product_description": "S-HYDROXOCOBA 5000MCG/ML INJ, 30ML glass vial, Red Mountain Compounding Rx", "product_quantity": "1x30 Ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot#:  S05232019DT@01, Exp 8/23/19;"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207792"], "brand_name": ["ISOTRETINOIN"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1017", "69238-1174", "69238-1175", "69238-1176"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930"], "spl_id": ["c2645360-e4a8-4737-9065-3dbbd4b6e6b7"], "spl_set_id": ["c2917c3d-3499-48a0-ba53-120cb979195d"], "package_ndc": ["69238-1174-1", "69238-1174-3", "69238-1175-1", "69238-1175-3", "69238-1017-1", "69238-1017-3", "69238-1176-1", "69238-1176-3"], "is_original_packager": [true], "upc": ["0369238117530", "0369238117615", "0369238117639", "0369238117417", "0369238117516", "0369238117431", "0369238101737", "0369238101713"], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "84073", "recalling_firm": "Amneal Pharmaceuticals, Inc.", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalled product was distributed to retailers and wholesalers who may have further distribute the product.", "recall_number": "D-0321-2020", "product_description": "Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3", "product_quantity": "2460 cartons/3 blister cards/10 capsules each", "reason_for_recall": "Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.", "recall_initiation_date": "20191016", "center_classification_date": "20191113", "termination_date": "20201109", "report_date": "20191120", "code_info": "Batch Numbers: BL10917, BL11017,  BL11117, Exp. date 11/2019"}, {"status": "Terminated", "city": "Springfield", "state": "OR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82247", "recalling_firm": "Todd Holiday dba Sunstone Organics", "address_1": "4061 Main St Ste C", "address_2": "N/A", "postal_code": "97478-8136", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "California, Nebraska, Oregon, Washington", "recall_number": "D-0986-2019", "product_description": "Maeng Da Kratom, packaged in a) 25 gram powder (UPC 00859667007118), b) 50 gram powder (UPC 00859667007125), c) 100 gram powder (UPC 00859667007132), Sunstone Organics Springfield, Oregon 97473,  541-972-3327.", "product_quantity": "800 kilograms", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.", "recall_initiation_date": "20190213", "center_classification_date": "20190311", "termination_date": "20230214", "report_date": "20190313", "code_info": "Lot #124A"}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1726-2019", "product_description": "CVS Therapeutic Menthol Gel, 8 FL OZ (227 g) Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 48136 3", "product_quantity": "5017 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #'s 28L17, 31L17, 36L17, 40L17, 44L17 EXP 09/2019; 05M17, 09M17, 12M17, 13M17, 23M17 EXP 10/2019; 69P17, 72P17 EXP 11/2019; 42S17, 46S17 EXP 12/2019; 85C18, 86C18 EXP 03/2020; 31J18, 43J18, 55J18, 58J18, 18L18 EXP 07/2020."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0253-2020", "product_description": "S-TESTOSTERONE HALF ULTRA 125MG/ML MDV IN SESAME OIL (TEST CYP 100MG/TEST PROP 12.5MG/NANDROLONE DECA 12.5), Rx Only, 5ML glass vial. Red Mountain Compounding Rx.", "product_quantity": "1x5ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S05302019DT@03Exp 08/30/2019,"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0805-2019", "product_description": "Dr. King's SafeCare Rx VeinoPlex, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006626, NDC 57955-0066-2", "product_quantity": "245 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 062415H Exp. 06/18; 111516P Exp. 11/19; 062016D Exp. 06/19; 040717D Exp. 04/19"}, {"status": "Terminated", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80878", "recalling_firm": "ACP Nimble Buyer, Inc.", "address_1": "111 Coolidge St", "address_2": "", "postal_code": "07080-3801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0514-2019", "product_description": "Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37", "product_quantity": "58,176 units", "reason_for_recall": "Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.", "recall_initiation_date": "20190207", "center_classification_date": "20190220", "termination_date": "20200323", "report_date": "20190227", "code_info": "Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1166-2019", "product_description": "Phenylephrine 1 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1556-2019", "product_description": "ICEE LEMON LIME SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "13,068", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181128, Exp 11/27/2020; 20181129, Exp 11/28/2020"}, {"status": "Completed", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203072"], "brand_name": ["IRBESARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["IRBESARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-330", "43547-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "IRBESARTAN"], "rxcui": ["310792", "310793"], "spl_id": ["13ddf1e5-56aa-45f2-b7b7-a91c24d8c0b3"], "spl_set_id": ["72fa8cd4-bc2a-4a7d-8feb-2d60e077d801"], "package_ndc": ["43547-330-03", "43547-330-09", "43547-330-50", "43547-331-03", "43547-331-09", "43547-331-50"], "is_original_packager": [true], "upc": ["0343547331030", "0343547330033"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "81910", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "700 Atrium Dr", "address_2": "N/A", "postal_code": "08873-4107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0410-2019", "product_description": "Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg  Rx Only 90 count    Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang  317024 China     Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512     NDC 43547-330-09", "product_quantity": "2177 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20190118", "center_classification_date": "20190127", "report_date": "20190206", "code_info": "325B18004"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0759-2019", "product_description": "Dr. King's SafeCare Rx Bladder Formula Urinary, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955004523, NDC 57955-0094-2", "product_quantity": "500 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072815K Exp. 07/18; 080916F Exp. 08/19; 022117F Exp. 02/20; 052616P Exp. 05/19"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1610-2019", "product_description": "Migraine Off Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1237-2019", "product_description": "Vancomycin 1500 mg in NS 250 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "715 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED041916 Exp. 4/13/2019; ED051916 Exp. 4/14/2019; ED081916 Exp. 4/17/2019; ED091916 Exp. 4/18/2019; ED101916 Exp. 4/19/2019; ED111914 Exp. 4/20/2019"}, {"status": "Terminated", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021908"], "brand_name": ["AMITIZA"], "generic_name": ["LUBIPROSTONE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["64764-080", "64764-240"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LUBIPROSTONE"], "rxcui": ["616578", "617768", "794639", "794641"], "spl_id": ["c2ca8178-4da1-42d1-a8b9-ff66dca82649"], "spl_set_id": ["d474ac6a-444d-4aa6-9986-24be6fcf811d"], "package_ndc": ["64764-080-60", "64764-080-40", "64764-240-60", "64764-240-10", "64764-240-40"], "is_original_packager": [true], "nui": ["N0000175573", "N0000175456"], "pharm_class_epc": ["Chloride Channel Activator [EPC]"], "pharm_class_moa": ["Chloride Channel Activators [MoA]"], "unii": ["7662KG2R6K"]}, "product_type": "Drugs", "event_id": "82830", "recalling_firm": "MALLINCKRODT PHARMACEUTICALS", "address_1": "1425 Us Highway 206", "address_2": "N/A", "postal_code": "07921-2653", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-1295-2019", "product_description": "Amitiza (lubiprostone) capsules, 24 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-240-60", "product_quantity": "80,640 bottles", "reason_for_recall": "Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.", "recall_initiation_date": "20190513", "center_classification_date": "20190523", "termination_date": "20230717", "report_date": "20190529", "code_info": "Lot #: 3200626-61, Exp 02/2022"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0282-2020", "product_description": "S-TEST CYP 25MG/ML IN ETHYL OLEATE OIL MDV, Rx Only, a)5 ml b) 10 ml c) 13 ml glass vial, Red Mountain Compounding Rx.", "product_quantity": "91 x 5, 10, 13 ML glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S02192019DH@14, Exp 8/19/19; S02282019DH@06, Exp 8/28/19; S03142019DT@04, Exp 9/14/19; S03252019DH@03, Exp 9/25/19; S04102019DT@05, Exp 10/10/19; S05012019DT@03, Exp 11/1/19; S05022019DT@11, Exp 11/2/19;  s05012019dt@09, Exp 11/2/19; S5212019DH@14, Exp 11/21/19; S06032019DT@07, Exp 12/3/19; S06122019DT@08, Exp 12/12/19; S07162019DT@13, Exp 1/16/20; S07262019DH@05, Exp 1/26/20;  S05212019DH@14, Exp 8/21/19;"}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["WALGREENS ADULT GLYCERIN"], "generic_name": ["GLYCERIN SUPPOSITORY"], "manufacturer_name": ["Walgreens"], "product_ndc": ["0363-0445"], "product_type": ["HUMAN OTC DRUG"], "route": ["RECTAL"], "substance_name": ["GLYCERIN"], "rxcui": ["104155"], "spl_id": ["2a1da51b-c01d-f982-e063-6394a90ad611"], "spl_set_id": ["1a00ff43-ba79-4339-a547-f9757872958b"], "package_ndc": ["0363-0445-25"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["PDC6A3C0OX"]}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1728-2019", "product_description": "Adult Glycerin Suppositories, Package Size 25-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0445-25,", "product_quantity": "98 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot # 01K17, 02K17 -Exp 08/2019"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1777-2019", "product_description": "Fluorouracil 560 MG / 11.2 ML IVP; Fluorouracil 3340 MG QS 92 ML 0.9% NACL; Fluorouracil 3920 MG QS 92 ML 0.9% NACL; Fluorouracil 3760 mg QS 100 ml NS CASS; Fluorouracil 4000 MG QS 92 ml 0.9% NACL; Fluorouracil 3140 MG QS 240 ML NS PUMP; Fluorouracil 2400 MG QS 96 ML 0.9% NACL  Fluorouracil 5000 MG QS 101 ml 0.9% NACL; Fluorouracil 750 MG / 15 ML IVP  Fluorouracil 4500 mg QS 100 ml NS CASS; Fluorouracil 4100 mg QS 100 ml NS CASS; Fluorouracil 690 mg / 13.8 ml IVP; Fluorouracil 2400 MG QS 96 ML NS IV; Fluorouracil 812 MG/16.24 ML IVP; Fluorouracil 4872 MG QS 240 ML NS PUMP; Fluorouracil 4200 mg QS 100 ml NS CASS; Fluorouracil 1110 MG QS 96 ml NS IVPB; Fluorouracil 370 MG/ 50 ML NS; Fluorouracil 620 MG/ 12.4 ML SYRINGE IVP; Fluorouracil 3160 MG QS 92 ML 0.9% NACL; Fluorouracil 1050 mg QS 92 ml NS IVPB; Fluorouracil 370 MG /100 ML NS IVPB; Fluorouracil 4080 MG QS  1000 ML NS IVPB; Fluorouracil 5 MG / 0.1 ML SYRINGE; Fluorouracil 5040 MG QS 101 ml NS CADD; Fluorouracil 4224 MG QS 100 ml NS CASS; Fluorouracil 700 MG / 14 ML IVP; Fluorouracil 3550 mg QS 92 ML 0.9% NACL IV; Fluorouracil 760 MG / 15.2 ML IVP; Fluorouracil 4560 MG QS 240 ML NS PUMP; Fluorouracil 796 MG / 15.92 MLIVP  Fluorouracil 4776 MG QS 240 ML NS PUMP; Fluorouracil 930 MG QS 240 ML NS PUMP; Fluorouracil 730 MG / 14.6 ML IVP SYR; Fluorouracil 4400 MG QS 100 ml NS CADD; Fluorouracil 2430 MG QS 96 ml 0.9% NACL; Fluorouracil 4728 MG QS 100 ml NS CASS; Fluorouracil 3550 MG QS 92 ML 0.9% NACL  Fluorouracil 588 MG / 11.76 ML IVP; Fluorouracil 3528 MG QS 240 ML NS PUMP; Fluorouracil 2520 mg QS 96 ml NS IVPB; Fluorouracil 790 MG / 15.8 ml IVP; Fluorouracil 4750 mg QS 97 ml 0.9% NACL IV; Fluorouracil 2660 MG QS 96 ml NS IVPB; Fluorouracil 720 MG/ 14.4 ML IVP; Fluorouracil 4370 mg QS 92 ml 0.9% NACL IV; Fluorouracil 3280 MG QS 92 ML 0.9% NACL; Fluorouracil 780 MG / 15.6 ML IVP; Fluorouracil 4660 MG QS 97 ml 0.9% NACL  Fluorouracil 3620 MG QS 100 ml NS CASS; Fluorouracil 2370 MG QS 92 ML 0.9% NACL; Fluorouracil 800 MG / 16 ML IVP; Fluorouracil 4800 MG QS 101 ml NS CADD; Fluorouracil 4000 mg QS 92 ML 0.9% NACL IV; Fluorouracil 2480 MG QS 96 ML 0.9% NACL; Fluorouracil 688 MG / 13.76 ml IVP  Fluorouracil 4128 MG QS 1000 ML D5W IVPB; Fluorouracil 6000 MG QS 250 ml NS CASS; Fluorouracil 672 MG / 13.44 ML IVP; Fluorouracil 4032 MG / 1000 ML D5W IVPB; Fluorouracil 894 MG / 17.88 ml IVP; Fluorouracil 400 MG / 50 ML NS IVPB; Fluorouracil 840 MG / 16.8 ml IVP; Fluorouracil 590 MG/ 11.8 ML IVP, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1101-2019", "product_description": "PAPAVERINE-PHENTOLAMINE-PGE1  30-2 MG-30 MCG/ML*  INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "1 prescription, 5ml injectable", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot:15112018@40  , distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0403-2019", "product_description": "Cyclosporin liquid 1%, Rx, plastic dropper bottle", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "07192018@12"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0825-2019", "product_description": "Dr. King's SafeCare Rx Hemorrhoid Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955002321, NDC 57955-0023-2", "product_quantity": "145 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 052516P Exp. 05/19; 091316B Exp. 09/19"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of sterility assurance.", "address_2": "", "product_quantity": "808 droptainers", "code_info": "Lot #: 138-20190205@3, Exp . Date 10/29/2019; 138-20190705@7, Exp. Date 11/3/2019", "center_classification_date": "20191018", "distribution_pattern": "Nationwide within the United States", "state": "AZ", "product_description": "Povidone Iodine, 5% Ophthalmic Solution, 5 mL per droptainer, Repackaged by:  Avella Specialty Pharmacy, 24416 N. 19th Ave., Phoenix, AZ 85085.  NDC 42852-006-20", "report_date": "20191030", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0152-2020", "initial_firm_notification": "", "product_type": "Drugs", "event_id": "83833", "termination_date": "20191204", "more_code_info": "", "recall_initiation_date": "20190918", "postal_code": "85085-1887", "voluntary_mandated": "", "status": "Terminated"}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0404-2019", "product_description": "Cyclosporin liquid 0.5%, Rx, plastic dropper bottle", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "07272018@2"}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83146", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1423-2019", "product_description": "Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*, 30mg/mL, 1mL Sterile Single-Use Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-104-10, barcode 7 69623 10410 5.", "product_quantity": "4363 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.", "recall_initiation_date": "20190618", "center_classification_date": "20190621", "termination_date": "20211026", "report_date": "20190703", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0177-2020", "product_description": "Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)95 count bottles (NDC 71713-203-05)  (Thirty Madison) OTC.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0089-2020", "product_description": "PHENYephrine HCl in 0.9% Sodium Chloride (PF) (Contains Sulfites). 30 mg/250 mL (0.12 mg/mL),  250 mL Single-Dose Bag For IV Infusion Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678401", "product_quantity": "60 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040278"], "brand_name": ["FLUOROURACIL"], "generic_name": ["FLUOROURACIL"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FLUOROURACIL"], "rxcui": ["239177", "1791701", "1791736"], "spl_id": ["d4cec285-6dd2-48ad-9045-b0d1baf1bfe2", "8ad197d1-c61c-41a1-bba4-ce5b7d1e8696"], "spl_set_id": ["beb8c6c5-4b6e-4770-b6d4-718e33c7a2ff", "b4328ae3-f48f-40b1-9719-1c1aced7c734"], "package_ndc": ["63323-117-51", "63323-117-61", "63323-117-59", "63323-117-69"], "is_original_packager": [true], "upc": ["0363323117610", "0363323117511", "0363323117597", "0363323117696"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["U3P01618RT"]}, "product_type": "Drugs", "event_id": "83234", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "2045 Cornell Ave", "address_2": "N/A", "postal_code": "60160-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1489-2019", "product_description": "Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by:  Fresenius Kabi, Lake Zurich, IL 60047.  63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]", "product_quantity": "14,016 vials", "reason_for_recall": "Presence of Particulate Matter; glass particulates", "recall_initiation_date": "20190628", "center_classification_date": "20190717", "termination_date": "20220920", "report_date": "20190724", "code_info": "Lot 6120420 NDC 63323-117-61, Product Code 101761 and Lot 6120341 NDC 63323-117-69, Product Code NP101761"}, {"status": "Terminated", "city": "Waynesboro", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81811", "recalling_firm": "Duren Health Mart Pharmacy", "address_1": "215 Dexter L Woods Memorial Blvd", "address_2": "N/A", "postal_code": "38485-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TN only", "recall_number": "D-0420-2019", "product_description": "Progesterone 100 mg SR capsules, 30-180 capsules per prescription, Rx only,  Duren's Health Mart Pharmacy  215 Dexter Woods Blvd. Waynesboro, TN38485, NDC 00311-2003-01", "product_quantity": "1306 capsules", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20181217", "center_classification_date": "20190128", "termination_date": "20220119", "report_date": "20190206", "code_info": "N/A"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0606-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Mental Alertness, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955505426, NDC 57955-5954-2", "product_quantity": "213 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021016H Exp.02/19; 061316A Exp. 06/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0544-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Scar Freee, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955508724, NDC 57955-5087-2", "product_quantity": "1339 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 031516B Exp. 03/19; 041817A Exp. 04/20; 050216H Exp. 05/19; 081117B Exp. 08/19; 091015D Exp. 09/18"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83200", "recalling_firm": "Geritrex, LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1524-2019", "product_description": "Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. 1650 63rd Street Brooklyn, NY 11204, NDC 52807-177-16", "product_quantity": "3864 bottles", "reason_for_recall": "cGMP Deviations: Products may have microbial contamination.", "recall_initiation_date": "20190531", "center_classification_date": "20190725", "termination_date": "20240202", "report_date": "20190731", "code_info": "Lot #: 70601, Exp 6/19"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1766-2019", "product_description": "DECITABINE 40 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Grover Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83339", "recalling_firm": "H J Harkins Company Inc dba Pharma Pac", "address_1": "1400 W Grand Ave Ste F", "address_2": "N/A", "postal_code": "93433-4221", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in California", "recall_number": "D-1580-2019", "product_description": "Neomycin 3.5 mg/g / Polymyxin B10000 USP Units/g / Dexamethasone 1 mg/g Ophthalmic Ointment, 3.5 g tube, Rx only, Manufactured for H.J. Harkins Company, Inc. dba Pharma Pac by Perrigo Co, Allegan, MI 49010, NDC 52959-0407-01", "product_quantity": "97 boxes", "reason_for_recall": "CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.", "recall_initiation_date": "20190712", "center_classification_date": "20190731", "termination_date": "20230605", "report_date": "20190807", "code_info": "Lot #: NPD10RP, Exp 08/19; NPD11RP, Exp 09/19; NPD12RP, Exp 11/19; NPD13RP, Exp 02/20; NPD14RP, Exp 02/20; NPD15RP, Exp 05/20; NPD16RP, Exp 06/20; NPD17RP, Exp 01/21; NPD18RP, Exp 02/21"}, {"status": "Terminated", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84401", "recalling_firm": "Surgery Pharmacy Services Inc", "address_1": "3908 Tennessee Ave Ste C", "address_2": "N/A", "postal_code": "37409-1357", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed in GA, TN", "recall_number": "D-0611-2020", "product_description": "Trisodium Citrate 0.5% CRRT SOLUTION. RX Only. Rx # specific and Patient Specific volumes. Mixed by Surgery Pharmacy Services,3908 TENN.AVE. CHATT,TN37409", "product_quantity": "84 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190530", "center_classification_date": "20191209", "termination_date": "20210204", "report_date": "20191218", "code_info": "RX numbers from 311976 to 314888", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0074-2020", "product_description": "Magnesium Chloride Hexahydrate 82.5 mg/mL; Calcium Gluconate 30 mg/mL (PF), For IV Use, 10 mL Single Dose vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678355", "product_quantity": "878 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1589-2019", "product_description": "Awake, 500 mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0413-2020", "product_description": "CVS Health Lubricant Eye Ointment Sensitive Formula, Item#: 247885, 3.5 gram, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "24,024 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "QHE 08/19   QJD 10/19"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0173-2020", "product_description": "Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80 count bottles (NDC 69842-871-80)  c.)160 count bottles (NDC 69842-871-37) (CVS) OTC", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0088-2020", "product_description": "PHENYephrine HCl in 0.9% Sodium Chloride (PF) (Contains Sulfites),  25 mg / 250 mL (0.1 mg/mL), 250 mL Single-Dose Bag For IV Infusion Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321677861", "product_quantity": "708 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202519"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-547", "65862-548", "65862-549", "65862-550", "65862-551"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["81a03db7-4be2-478d-b625-e59c8bd2235f"], "spl_set_id": ["c5bc7c55-b50c-4e61-ad1f-5ebb607c262f"], "package_ndc": ["65862-547-90", "65862-547-99", "65862-547-10", "65862-548-90", "65862-548-99", "65862-548-10", "65862-549-90", "65862-549-99", "65862-549-10", "65862-550-90", "65862-550-05", "65862-551-90", "65862-551-05"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81887", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.", "recall_number": "D-0368-2019", "product_description": "Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-547-90.", "product_quantity": "32,160 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181231", "center_classification_date": "20190114", "report_date": "20190123", "code_info": "Lot # HVSA17011-A, exp. date 11/2020  Lot # HVSA17012-A, exp. date 11/2020  Lot # HVSA18001-A, exp. date 12/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0761-2019", "product_description": "Dr. King's SafeCare Rx Headache Freee... U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955015321 NDC 57955-0153-2", "product_quantity": "438 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022516D Exp. 02/19; 080916A Exp. 08/19; 121317K Exp. 12/19"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0031-2020", "product_description": "C-PHENOL/COTTONSEED OIL INJ 5%, 5 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 070319F, BUD 08/17/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0916-2019", "product_description": "NET Remedies #20 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "1300 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-011916N Exp. 01/19; AUS-050516K Exp. 05/19; AUS-091515J Exp. 09/18; AUS-101416A Exp. 10/19"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1365-2019", "product_description": "Phenobarbital Oral Solution, USP, 20 mg per 5 mL, Rx Only, One Pint (473 mL) bottle, NDC:16571-330-16, Manufactured by Bio-Pharm Inc., Levittown, PA 10957, Distributed by Rising Pharmaceuticals Inc., Saddle Brook, NJ 07663.", "product_quantity": "148,440 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17E007, Exp. 05/2019; 17F026, Exp. 06/2019; 17G015, Exp. 07/2019; 17K002; 17K026, Exp. 10/2019; 17M002, Exp. 12/2019; 18C020, Exp. 03/2020; 18D023, Exp. 04/2020; 18F009, Exp. 06/2020; 18K030, Exp. 10/2020."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0655-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Allergy & Red Eye Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955516422, NDC 57955-5164-2", "product_quantity": "453 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 081117A Exp. 08/19; 123016A Exp. 12/19"}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125526"], "brand_name": ["NUCALA"], "generic_name": ["MEPOLIZUMAB"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0881", "0173-0892", "0173-0904"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["MEPOLIZUMAB"], "rxcui": ["1720601", "1720606", "2170990", "2170993", "2173820", "2173822", "2596444", "2596445"], "spl_id": ["869b75ba-b2a0-406e-9ed2-136b75763d78"], "spl_set_id": ["fefb887c-e4ac-431e-8893-e9d1a5a63fea"], "package_ndc": ["0173-0881-01", "0173-0881-61", "0173-0892-01", "0173-0892-42", "0173-0892-61", "0173-0892-63", "0173-0904-42"], "is_original_packager": [true], "nui": ["N0000191872", "N0000191871"], "pharm_class_epc": ["Interleukin-5 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-5 Antagonists [MoA]"], "unii": ["90Z2UF0E52"]}, "product_type": "Drugs", "event_id": "83731", "recalling_firm": "Cardinal Health dba Specialty Pharmaceutical Services", "address_1": "15 Ingram Blvd", "address_2": "", "postal_code": "37086-3630", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1876-2019", "product_description": "Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.", "product_quantity": "38 syringes", "reason_for_recall": "Temperature Abuse; Product stored and shipped outside of labeled storage requirements.", "recall_initiation_date": "20190906", "center_classification_date": "20190920", "termination_date": "20201008", "report_date": "20191002", "code_info": "Lot #: S25X, Exp. 03/31/21", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1626-2019", "product_description": "Appetrol Capsules, Distributed by Herbal Doctor Remedies, Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Stockton", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82477", "recalling_firm": "Pacific Compounding Pharmacy & Consultations Inc", "address_1": "312 Lincoln Ctr", "address_2": "N/A", "postal_code": "95207-2627", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "California", "recall_number": "D-1076-2019", "product_description": "Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CA", "product_quantity": "41.4 mL", "reason_for_recall": "Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper", "recall_initiation_date": "20180823", "center_classification_date": "20190402", "termination_date": "20230427", "report_date": "20190410", "code_info": "Lot # 07232018@15 BUD 9/6/18 (frozen)"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0044-2020", "product_description": "L-Carnitine 27 mL in a 30 mL Vial, 4,590 mg/27 mL (170 mg/mL) Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674166", "product_quantity": "10014 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Tamarac", "address_1": "10200 NW 67th St", "reason_for_recall": "CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.", "address_2": "", "product_quantity": "1344 cartons", "code_info": "Lot: 80054 Exp. 10/31/20", "center_classification_date": "20190523", "distribution_pattern": "Nationwide and Venezuela", "state": "FL", "product_description": "DrKids Children's Cough & Chest Congestion DM, Dextromethorphan HBr 5 mg Guaifenesin 100 mg Mixed Berry Flavor 20 Pre-measured Singe-Use 0.17 fl. oz. (5 mL), Manufactured in USA by: Unipharma, LLC. Tamarac, FL 33321, NDC 70302-013-20, UPC 370302268010", "report_date": "20190522", "classification": "Class II", "openfda": {}, "recalling_firm": "Unipharma, Llc.", "recall_number": "D-1301-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82754", "termination_date": "20201125", "more_code_info": "", "recall_initiation_date": "20190502", "postal_code": "33321-6404", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84233", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ, IA, MA, MO", "recall_number": "D-0308-2020", "product_description": "GSMS: Ranitidine Capsules 300 mg, Rx only, 100 count bottles (NDC 51407-098-01) Manufactured by Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520; Packaged by GSMS, Incorporated, Carmillo, CA 93012 USA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191106", "center_classification_date": "20191110", "termination_date": "20210415", "report_date": "20191120", "code_info": "Lot Codes: GS023971, Exp. 10/31/2020; GS025527, Exp. 10/31/2020; GS025526, Exp. 10/31/2020; GS026114, Exp. 10/31/2020; GS025813, Exp. 10/31/2020; GS026189, Exp. 10/31/2021; GS027555, Exp. 7/31/2021; GS026190, Exp. 5/31/2021; GS026220, Exp. 05/31/2021; GS026584, Exp. 05/31/2021; GS027139, Exp. 05/31/2021; GS027554, Exp. 05/31/2021."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0869-2019", "product_description": "Dr. King's SafeCare Rx Environmental Adaptation Hot/Humid, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955028529, NDC 57955-0285-2", "product_quantity": "115 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots; 081015K Exp. 08/18; 071316H Exp. 07/19; 111716J Exp. 11/19"}, {"status": "Terminated", "city": "Addison", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84006", "recalling_firm": "Innoveix Pharmaceuticals Inc", "address_1": "3790 Arapaho Rd", "address_2": "", "postal_code": "75001-4311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0159-2020", "product_description": "Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910", "product_quantity": "1747 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20191010", "center_classification_date": "20191028", "termination_date": "20220114", "report_date": "20191106", "code_info": "Lots: SER 925 Exp. 11/4/19; SER 930 Exp. 11/18/19; SER 935 Exp. 2/21/20; SER 400 Exp. 4/1/20; SER 405 Exp. 5/11/20; SER 410 Exp. 7/15/20", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1634-2019", "product_description": "Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0173-10", "product_quantity": "N/A", "reason_for_recall": "Crystallization", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1234-2019", "product_description": "Sodium Citrate 4%, 40 mg/mL, 3 mL syringe, Flush Syringe,  Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "40 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED031915 Exp. 4/17/2019; ED041919 Exp. 4/18/2019; ED091914 Exp. 4/23/2019; ED111912 Exp. 4/25/2019"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1500-2019", "product_description": "Dermanak original crema blanqueador (Hydroquinone 2%) Skin Fade Cream, 2 OZ. (56.7 g) jar, Manufactured by: Pamby Distributors, Inc., Miami, FL 33126, NDC 63788-108-02.", "product_quantity": "1032 jars", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1360-2019", "product_description": "Hyoscyamine Sulfate Elixir 0.125 mg per 5 mL, Rx Only, 473 mL (16 oz.) bottle, NDC:39328-048-16, Patrin Pharma, Skokie IL 60076.", "product_quantity": "24,384 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17F021, Exp. 06/2019; 17G013, Exp. 07/2019; 17K010, Exp. 10/2019; 18E015, Exp. 05/2020; 18F029; 18F031; 18F042, Exp. 06/2020; 18G024, Exp. 07/2020."}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1533-2019", "product_description": "festpak clearly fun SPF30 sunscreen lotion SPF 30 SUNSCREEN LOTION Active Ingredients Octinoxate 7.5%, Octisalate 2.0%, Oxybenzone 4.0% Titanium Dioxide 2.5% Sunscreen Distributed by: festpak - Austin, TX 78732 Made in China", "product_quantity": "20, 000", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181008, Exp 10/07/2020; 20181009, Exp 10/08/2020"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1673-2019", "product_description": "MAGNESIUM 200 MG/ML/ CALCIUM GLUC 6MG/ML/ ZINC 1MG/ML, 5ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0176-05", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0480-2020", "product_description": "Nano Tears XP Clear Emollient Lubricant Gel Drops twin pack, Product Size: 2 x 10 mL, Mfd. by: Altaire Pharmaceuticals, Inc., Aquebogue, NY 11931, NDC 59390-143-51", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17366, Exp 12/19"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1644-2019", "product_description": "CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0946-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1213-2019", "product_description": "Magnesium Sulfate 1 GM in NS 50 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "2162 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EK051810 Exp. 5/4/2019; EK281808 Exp. 5/27/2019; EL101810 Exp. 6/8/2019; EL141807 Exp. 6/12/2019; EA081910 Exp. 7/7/2019; EA161908 Exp. 7/15/2019; EA301908 Exp. 7/29/2019; EB111907 Exp. 8/10/2019; EC041907 Exp. 8/31/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0524-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Regional Allergies Northeastern U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955519225, NDC 57955-0753-2", "product_quantity": "3651 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 030817M Exp. 03/19; 050216E Exp. 05/19; 070816D Exp. 07/19; 010118D Exp. 01/20; 030418B Exp. 03/20"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1151-2019", "product_description": "HCG 20 Day Extra Strength, 3500 Units/4 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "99 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA204147"], "brand_name": ["PROCHLORPERAZINE EDISYLATE"], "generic_name": ["PROCHLORPERAZINE EDISYLATE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-294"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["PROCHLORPERAZINE EDISYLATE"], "rxcui": ["2102949"], "spl_id": ["aa344274-7751-40fa-b8d9-3ad2c340d793"], "spl_set_id": ["0dc48e66-6081-421b-952b-4867c9c4c794"], "package_ndc": ["23155-294-31", "23155-294-42", "23155-294-41"], "is_original_packager": [true], "upc": ["0323155294316"], "unii": ["PG20W5VQZS"]}, "product_type": "Drugs", "event_id": "82918", "recalling_firm": "Heritage Pharmaceuticals, Inc.", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1397-2019", "product_description": "PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India. Mfg for: Heritage Pharmaceuticals Inc. NDC 23155-294-31", "product_quantity": "55,480 2 mL vials", "reason_for_recall": "Non-Sterility:Microbial growth detected in  sub lot of  Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .", "recall_initiation_date": "20190521", "center_classification_date": "20190619", "termination_date": "20220111", "report_date": "20190619", "code_info": "Lot: VPCA172, EXP April 2020"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0047-2020", "product_description": "ePHEDrine Sulfate in 0.9% Sodium Chloride (PF) 25 mg/5 mL (5 mg/mL) 5 mL Fill in a 6 mL Syringe, Single Dose Syringe, Rx Only,  KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678374", "product_quantity": "12445 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0449-2019", "product_description": "Sermorelin 9 mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "255 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 06182018@2 BUD: 12/15/2018; 08212018@12 BUD: 2/17/2019; 09212018@15 BUD: 3/20/2019; 11132018@1 BUD: 5/12/2019"}, {"country": "United States", "city": "Tamarac", "address_1": "10200 NW 67th St", "reason_for_recall": "CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.", "address_2": "", "product_quantity": "39216 cartons", "code_info": "Lot: 80062 Exp. 11/30/20", "center_classification_date": "20190523", "distribution_pattern": "Nationwide and Venezuela", "state": "FL", "product_description": "DrKids Children's Natural Cough Syrup English Ivy Leaf Organic Agave Nectar Pre-measured Single-Use 0.17 fl. oz. (5 mL), Manufactured in USA by: Unipharma, LLC. Tamarac, FL 33321, UPC 370302489019", "report_date": "20190522", "classification": "Class II", "openfda": {}, "recalling_firm": "Unipharma, Llc.", "recall_number": "D-1303-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82754", "termination_date": "20201125", "more_code_info": "", "recall_initiation_date": "20190502", "postal_code": "33321-6404", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0584-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Morning Sickness Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955500827, NDC 57955-6008-2", "product_quantity": "452 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 040616K Exp. 04/2019; 072716J Exp. 07/2019"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10030060 Exp. 11/21/2019,  10030574 Exp. 11/28/2019,  10031353 Exp. 12/12/2019,  10031677 Exp. 12/20/2019,  10031622 Exp. 12/19/2019,  10031419 Exp. 12/15/2019,  10031769 Exp. 12/26/2019,  10031826 Exp. 12/23/2019,  10032287 Exp. 12/30/2019", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vial Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1180-79", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0570-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84144", "recalling_firm": "ICU Medical Inc", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0349-2020", "product_description": "LACTATED RINGER'S Injection, USP, 500 mL flexible container, Rx Only, Hospira, Inc., Lake Forest, IL 60045. NDC 0409-7953-03", "product_quantity": "389,808 bags", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20191025", "center_classification_date": "20191115", "termination_date": "20220120", "report_date": "20191113", "code_info": "Lot: 84-603-FW Exp. 01 DEC 2019"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0475-2020", "product_description": "Equate Support Advanced Lubricant Gel Drops Multi Dose Preservative Free, 7.5 mL, NDC 49035-882-52", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "19015 01/21   19117 04/21   18080 07/20   18111 05/20"}, {"status": "Terminated", "city": "San Luis Obispo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84284", "recalling_firm": "Integrated Health Concepts Inc. dba Conversio Health", "address_1": "720 Aerovista Pl Ste D", "address_2": "N/A", "postal_code": "93401-8726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0514-2020", "product_description": "Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20191112", "center_classification_date": "20191119", "termination_date": "20200528", "report_date": "20191127", "code_info": "All lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0766-2019", "product_description": "Dr. King's SafeCare Rx Allergies: Mold, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955650126, NDC 57955-6501-2", "product_quantity": "1329 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072015D Exp. 07/18; 022317F Exp. 02/20; 123015B Exp. 12/18; 062816B Exp. 06/19; 091616B Exp. 09/19"}, {"country": "United States", "city": "Camarillo", "address_1": "5187 Camino Ruiz", "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.", "address_2": "", "product_quantity": "14,955 bottles (1,345,950 tablets)", "code_info": "Lot #: GS017651, Expiration 01/2020", "center_classification_date": "20190709", "distribution_pattern": "US Nationwide One (1) US government account. No foreign accounts.", "state": "CA", "product_description": "Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90", "report_date": "20190717", "classification": "Class II", "openfda": {}, "recalling_firm": "Golden State Medical Supply Inc.", "recall_number": "D-1463-2019", "initial_firm_notification": "", "product_type": "Drugs", "event_id": "83161", "termination_date": "20200219", "more_code_info": "", "recall_initiation_date": "20190614", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1347-2019", "product_description": "Allergy Liquid Antihistamine, Diphenhydramine HCl USP 12.5 mg/5 mL), Alcohol free, 4 FL. oz. (118 mL) bottle, NDC: 59741-119-06, Manufactured by Bio-Pharm Inc., Levittown, PA 19057, Assured.", "product_quantity": "118,080 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17E019; 17E045, Exp. 05/2019"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0392-2020", "product_description": "CVS Health Maximum Redness Relief Lubricant Redness Reliever Eye Drops, Sterile, 0.5 fl. oz. (15 mL), Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "483528 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17251 8/19  17269 9/19  17360 12/19  18012 1/20  18106 4/20  18275 11/20  18275 11/20"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206880"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM INJECTION"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-635", "43598-636", "43598-637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["1193358", "1193360", "1193362"], "spl_id": ["f5cfc6e1-79f3-bd25-5f66-9ea05bc47def"], "spl_set_id": ["0a9234b7-46b1-8e6c-a992-90f86cfb6e00"], "package_ndc": ["43598-635-52", "43598-635-10", "43598-636-52", "43598-636-10", "43598-637-52", "43598-637-10", "3435986375"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"], "upc": ["343598637525"]}, "product_type": "Drugs", "event_id": "81441", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0485-2019", "product_description": "Levetiracetam in 0.54 % Sodium Chloride Injection 1,500/mg/100mL (15mg/mL), For intravenous Infusion Only, 1 x 100 mL Infusion bag, Manufactured by: Gland Pharma Limited Hyderabad - 500 043, India Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 UPC 343598637525 ---- NDC 43598-637-52", "product_quantity": "2770 bags; 277 selling units", "reason_for_recall": "Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000 mg/100 mL) however, the external foil pouch correctly identifies the product as Levetiracetam in 0.54% Sodium Chloride Injection (1,500/100 mL).", "recall_initiation_date": "20181026", "center_classification_date": "20190211", "termination_date": "20230404", "report_date": "20190220", "code_info": "ABD807, exp 05/2020"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82661", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1268-2019", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP, 100mg/12.5mg, a) 90-count (NDC: 13668-117-90), b) 1000-count (NDC: 13668-117-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India", "product_quantity": "54,084 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the  finished product above the interim acceptable daily intake level.", "recall_initiation_date": "20190418", "center_classification_date": "20190501", "report_date": "20190508", "code_info": "Count, lots, expiry: [90-count bottle] Lot BX35D024, exp 1/31/2020; BEF8D060, BEF8D061, BEF8D062, BEF8D063, BEF8D064, exp 11/30/2020; [1000-count bottle] Lot BEF8D059, exp 11/30/2020; Lots BEF8E004, BEF8E005, exp 1/31/2021"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1692-2019", "product_description": "PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1492-2019", "product_description": "Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief (Capsaicin 0.2%) Topical Analgesic Cream, 4 OZ (113.4 g) bottle with pump, Distributed by: Coast to Coast Natural, Inc., Wellington, FL 33414, NDC 63788-120-04.", "product_quantity": "998 bottles", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1775-2019", "product_description": "ERIBULIN 1.12 MG / 100 ML NS IVPB; ERIBULIN 1.87 MG / 100 ML NS IVPB;  ERIBULIN 1.89 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1724-2019", "product_description": "CVS Health Glycerin Suppositories, 50-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 33106 4", "product_quantity": "144 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #'s 52J17, 53J17, 54J17, 55J17, 59J17, 60J17 EXP 07/2019"}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1477-2019", "product_description": "Methylcobalamin 1 mg/mL Injection, 8 mL vial,  Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "8 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 06102019@6, Exp. 08/09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1758-2019", "product_description": "CETUXIMAB 335 MG / 167.5 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1662-2019", "product_description": "GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0971-81", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0733-2019", "product_description": "Dr. King's SafeCare Rx Repressed Sexual Issues Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955126027, NDC 57955-1261-2", "product_quantity": "29 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 061716B Exp. 06/19; 012517K Exp. 01/20"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0696-2019", "product_description": "Dr. King's Natural Medicine Cooling Acute Pain Relief Pure Homeopathic Cream, 3 oz. (85 g), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955400134,  NDC 57955-4001-3", "product_quantity": "12280 tubes", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060816 Exp. 06/19; 081717ZZ Exp. 08/19; 110117ZZ Exp. 11/20; 045017ZZ Exp. 04/20; 100516ZZ Exp. 06/19; 111016ZZ Exp. 11/19"}]